Zandelisib, CAS 1401436-95-0

Product Description: Zandelisib (ME-401) is a phosphatidylinositol 3-kinase (PI3K) inhibitor extracted from patent WO2019183226 A1, Compound Example 1. Zandelisib selectively inhibits p110δ with an IC50 of 3.5 nM. Zandelisib functions as an antineoplastic[1][2].

Applications: Cancer-Kinase/protease

Formula: C31H38F2N8O

References: [1]Daniel P. Gold, et al. Combination therapy. WO2019183226A1./[2]David Brown, et al. (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases. WO2014055647A1.

CAS Number: 1401436-95-0

Molecular Weight: 576.68

Compound Purity: 99.90

Research Area: Cancer

Solubility: DMSO : 9.09 mg/mL (ultrasonic)

Target: PI3K

• Artikelnummer: MEXHY-109198-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-109198-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK